AG真人官方

Brink's Company (BCO) 鈥� Form 4 insider transaction

Executive Vice President & Chief Financial Officer Kurt B. McMaken reported an automatic, compensation-related acquisition of 82.21 Program Units on 30 June 2025 under the Key Employees' Deferred Compensation Program. Each Program Unit is economically equivalent to, and will ultimately settle in, one share of BCO common stock. The acquisition price is based on the month-end closing price of $89.29 per share. Following this credit, the CFO now holds 4,008.17 derivative Program Units in direct ownership. No open-market cash was exchanged; the units were created through the monthly conversion of deferred salary and matching contributions. There were no sales or dispositions reported.

• The filing reflects routine deferred-compensation activity rather than discretionary share purchases.
• McMaken remains subject to Section 16 reporting and continues to accumulate equity exposure to BCO through the Program.

The transaction is administrative and non-dilutive, with negligible direct impact on Brink's capital structure or share count, but it can be viewed as a modest sign of ongoing insider alignment with shareholders.

Brink's Company (BCO) 鈥� Form 4 insider transaction

Executive Vice President & Chief Financial Officer Kurt B. McMaken reported an automatic, compensation-related acquisition of 82.21 Program Units on 30 June 2025 under the Key Employees' Deferred Compensation Program. Each Program Unit is economically equivalent to, and will ultimately settle in, one share of BCO common stock. The acquisition price is based on the month-end closing price of $89.29 per share. Following this credit, the CFO now holds 4,008.17 derivative Program Units in direct ownership. No open-market cash was exchanged; the units were created through the monthly conversion of deferred salary and matching contributions. There were no sales or dispositions reported.

• The filing reflects routine deferred-compensation activity rather than discretionary share purchases.
• McMaken remains subject to Section 16 reporting and continues to accumulate equity exposure to BCO through the Program.

The transaction is administrative and non-dilutive, with negligible direct impact on Brink's capital structure or share count, but it can be viewed as a modest sign of ongoing insider alignment with shareholders.

Form 4 overview: On 06/30/2025, Brink鈥檚 Company (BCO) President & CEO and Director Richard M. Eubanks reported the crediting of 127.39 Program Units to his Key Employees鈥� Deferred Compensation Program account. Each Program Unit is economically equivalent to one share of BCO common stock and will ultimately settle on a one-for-one basis in accordance with the executive鈥檚 deferral election (either after termination or on a pre-selected future date).

The Program Units were valued at $89.29, the closing price of BCO stock on the final trading day of the month. Following this routine transaction, Eubanks now beneficially owns 14,248.56 derivative securities linked to BCO common stock. Ownership is reported as direct.

Key points for investors:

• The filing reflects deferred compensation rather than an open-market purchase; therefore, it does not inject new cash into the shares.
• The incremental addition is modest (< 130 units) and unlikely to be material to Brink鈥檚 overall share dynamics.
• Nevertheless, continued participation in the deferral plan may be viewed as long-term alignment of the CEO鈥檚 interests with shareholders.

Form 4 overview: On 06/30/2025, Brink鈥檚 Company (BCO) President & CEO and Director Richard M. Eubanks reported the crediting of 127.39 Program Units to his Key Employees鈥� Deferred Compensation Program account. Each Program Unit is economically equivalent to one share of BCO common stock and will ultimately settle on a one-for-one basis in accordance with the executive鈥檚 deferral election (either after termination or on a pre-selected future date).

The Program Units were valued at $89.29, the closing price of BCO stock on the final trading day of the month. Following this routine transaction, Eubanks now beneficially owns 14,248.56 derivative securities linked to BCO common stock. Ownership is reported as direct.

Key points for investors:

• The filing reflects deferred compensation rather than an open-market purchase; therefore, it does not inject new cash into the shares.
• The incremental addition is modest (< 130 units) and unlikely to be material to Brink鈥檚 overall share dynamics.
• Nevertheless, continued participation in the deferral plan may be viewed as long-term alignment of the CEO鈥檚 interests with shareholders.

Form 4 overview: On 06/30/2025, Brink鈥檚 Company (BCO) President & CEO and Director Richard M. Eubanks reported the crediting of 127.39 Program Units to his Key Employees鈥� Deferred Compensation Program account. Each Program Unit is economically equivalent to one share of BCO common stock and will ultimately settle on a one-for-one basis in accordance with the executive鈥檚 deferral election (either after termination or on a pre-selected future date).

The Program Units were valued at $89.29, the closing price of BCO stock on the final trading day of the month. Following this routine transaction, Eubanks now beneficially owns 14,248.56 derivative securities linked to BCO common stock. Ownership is reported as direct.

Key points for investors:

• The filing reflects deferred compensation rather than an open-market purchase; therefore, it does not inject new cash into the shares.
• The incremental addition is modest (< 130 units) and unlikely to be material to Brink鈥檚 overall share dynamics.
• Nevertheless, continued participation in the deferral plan may be viewed as long-term alignment of the CEO鈥檚 interests with shareholders.

On July 1, 2025, Brink's Company (BCO) director Paul G. Boynton acquired 196 deferred stock units through the company's Director Fee Deferral Plan. Each unit is economically equivalent to one common share and was credited at $89.29, the closing price on the final trading day of the quarter. The units will convert to common stock on a one-for-one basis at a future date chosen by the director or upon termination of board service. Following the credit, Boynton now beneficially owns 10,099.95 deferred units. No shares were sold, and the filing reflects routine quarterly compensation rather than a discretionary market transaction; therefore, the impact on Brink's capital structure and public float is immaterial.

On July 1, 2025, Brink's Company (BCO) director Paul G. Boynton acquired 196 deferred stock units through the company's Director Fee Deferral Plan. Each unit is economically equivalent to one common share and was credited at $89.29, the closing price on the final trading day of the quarter. The units will convert to common stock on a one-for-one basis at a future date chosen by the director or upon termination of board service. Following the credit, Boynton now beneficially owns 10,099.95 deferred units. No shares were sold, and the filing reflects routine quarterly compensation rather than a discretionary market transaction; therefore, the impact on Brink's capital structure and public float is immaterial.

Community Healthcare Trust Inc. (CHCT) filed a Form 4 disclosing that its Executive Vice President & Chief Financial Officer, William G. Monroe IV, had a single reportable transaction on 30 June 2025.

• Transaction code F indicates shares were withheld to satisfy tax obligations associated with equity compensation.
• 650 shares of common stock were disposed of at an average price of $16.77 per share.
• Following the transaction, Monroe directly owns 149,759 CHCT common shares.
• No derivative securities were acquired or disposed of, and no other transactions were reported.

The filing was signed on 2 July 2025 by attorney-in-fact Nathanael P. Kibler.